This paper examines the associations among stressful life events, social support, and depressive symptoms in a sample of 580 first-time welfare recipients. Self-reported number of depressive symptoms was greater than in corresponding community samples. Stressors and social supports made independent main effect contributions to depressive symptoms in a multiple regression analysis. Women with transportation barriers to employment, those experiencing greater numbers of stressful life events, and those who were less satisfied with their housing situation reported greater numbers of depressive symptoms. In contrast, women who were more satisfied with their social support and those with higher attendance at religious services reported fewer depressive symptoms. Implications for welfare reform policy and programs are discussed.
Objective: The establishment of the Family Violence Option (FVO) in 1997 was met with some controversy, as critics believed waivers from time limit and work requirements would hinder women's ability to leave welfare and find employment. Method: Using administrative and interview data from Maryland, multivariate equations analyze if domestic violence disclosure, administrative documentation, or waiver use had a statistically significant affect on one year employment and welfare use outcomes of individuals. Results: Waiver holders did not differ from nonvictims, but victims who are not documented received fewer months of welfare and earned less income. Conclusions: Findings do not indicate that FVO waivers encourage women to stay on welfare longer. However, the poor outcomes of undocumented victims indicate that some individuals may be slipping through the cracks of a well-intentioned policy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.